Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tait

Showing results (261-270 of 274) with videos related to

Pageof 28
Sort By:
Medical Teacher|July 31, 2021
Ottawa 2020 consensus statements for programmatic assessment - 2. Implementation and practiceDario Torre, Neil E Rice, Anna Ryan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 24, 2023
Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart diseaseRenae K Barr, Bryce W Barber, Jessica R Tait, et al.
International Journal of Antimicrobial Agents|March 8, 2025
Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosaJ R Tait, A A Agyeman, C López-Causapé, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Neuroimage. Clinical|May 23, 2017
Advanced magnetic resonance imaging and neuropsychological assessment for detecting brain injury in a prospective cohort of university amateur boxersM G Hart, C R Housden, J Suckling, et al.
Translational Psychiatry|November 17, 2025
Perinatal brain growth and autistic traits in toddlersA Tsompanidis, K M Chang, Y T Khan, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2023
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and HeteroresistanceJessica R Tait, Marina Harper, Sara Cortés-Lara, et al.
ACS Nano|June 24, 2025
Asymmetric Porous Catalyst Structures for Low-Temperature Photocatalytic Dry Reforming of MethaneWilliam Moore, Shusaku Shoji, Lieihn Tsaur, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
The Lancet. Microbe|June 25, 2026
Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulationsSiobhonne K J Breen, Sara Cortés-Lara, Jessica R Tait, et al.
Pageof 28

Showing results (261-270 of 274) with videos related to

Sort By:
Pageof 28
Medical Teacher|July 31, 2021
Ottawa 2020 consensus statements for programmatic assessment - 2. Implementation and practiceDario Torre, Neil E Rice, Anna Ryan, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 24, 2023
Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart diseaseRenae K Barr, Bryce W Barber, Jessica R Tait, et al.
International Journal of Antimicrobial Agents|March 8, 2025
Multiomics informed mathematical model for meropenem and tobramycin against hypermutable Pseudomonas aeruginosaJ R Tait, A A Agyeman, C López-Causapé, et al.
Clinical Pharmacology and Therapeutics|February 7, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal ClearanceAkosua A Agyeman, Kate E Rogers, Jessica R Tait, et al.
Neuroimage. Clinical|May 23, 2017
Advanced magnetic resonance imaging and neuropsychological assessment for detecting brain injury in a prospective cohort of university amateur boxersM G Hart, C R Housden, J Suckling, et al.
Translational Psychiatry|November 17, 2025
Perinatal brain growth and autistic traits in toddlersA Tsompanidis, K M Chang, Y T Khan, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2023
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and HeteroresistanceJessica R Tait, Marina Harper, Sara Cortés-Lara, et al.
ACS Nano|June 24, 2025
Asymmetric Porous Catalyst Structures for Low-Temperature Photocatalytic Dry Reforming of MethaneWilliam Moore, Shusaku Shoji, Lieihn Tsaur, et al.
International Journal of Antimicrobial Agents|April 1, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencingSiobhonne K J Breen, Marina Harper, Carla López-Causapé, et al.
The Lancet. Microbe|June 25, 2026
Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulationsSiobhonne K J Breen, Sara Cortés-Lara, Jessica R Tait, et al.
Pageof 28